Risks of copper nanoparticles in cosmetics

.
.
.

On March 5, the European Scientific Committee on Consumer Safety (SCCS) published its final opinion on copper nanoparticles.
While the SCCS reports a lack of sufficient data (in terms of characterization and toxicology) to allow it to evaluate copper in nano forms, it nevertheless points to risks that warrant further evaluation of the safety of copper nanomaterials used as cosmetic ingredients. The main issues are: the risk of accumulation in certain organs – particularly the liver and spleen – linked to systemic exposure, and the potential mutagenic / genotoxic and immunotoxic / nephrotoxic effects.

About 30 cosmetic products have been reported to the SCCS by seven manufacturers.

Note: the SCCS also published on March 8 a “corrigendum” of its “Scientific advice on the safety of nanomaterials in cosmetics” published in January, incorporating the results of this assessment in its Annex I (where the risk potential score for copper in nano form was raised to 40, the highest score).

Upcoming Nano Agenda

27
Jan.
2026
Nanotechnologies and agriculture: a reference framework for responsible practice (AFNOR, online)
On line
Webinar
agriculture
pesticides
standardization
  • Webconference for analysis laboratories, plant fertilizer manufacturers and distributors, public authorities…
  • Moderated by David Krupka, nanotechnologies development manager at AFNOR Normalisation and Emilie Langlois-Bertrand, nantechnologies standardization project manager.
  • In partnership with Armand Masion, CNRS Research Director, and Sandrine Mocoeur, Health, Safety, Environment and Quality Manager at SYNGENTA.
  • This exchange will also be an opportunity to explore the creation of a national platform to identify standardization needs.
  • Website: www.afnor.org/evenement/nanotechnologies-agriculture-cadre-pratique-responsable/

2
Juin
2026
Emerging pathologies and risks (CNMST 2026, Lyon – France)
Lyon
Congress
health
health
occupational health
prevention
risks
  • 8th Congress of Occupational Medicine and Health (CNMST 2026)
  • Theme 5: Emerging pathologies and risks, Mr Henri Bastos (ANSES), Pr Lynda Bensefa-Colas (AP-HP), Dr Catherine Nisse (CHU Lille)
  • Website: www.medecine-sante-travail.com
26
Juin
2026
Nanomaterials and Health (ANSES, Maisons-Alfort)
Maisons-Alfort
Dialogue Committee